Quarterly report pursuant to Section 13 or 15(d)

Acquisitions - Schedule of Allocation of Purchase Price (Details)

v3.19.2
Acquisitions - Schedule of Allocation of Purchase Price (Details) - USD ($)
 3 Months Ended 10 Months Ended
Feb. 16, 2018
Nov. 17, 2017
Jun. 30, 2018
Sep. 30, 2018
Jun. 30, 2019
Dec. 31, 2018
Fair value of liabilities assumed:            
Fair value of debt assumed     $ (15,075,000)   $ 0  
Goodwill         $ 16,411,123 $ 16,411,123
Avadel            
Business Acquisition [Line Items]            
Inventory $ 718,000          
Prepaid expenses and other current assets 570,000          
Identifiable Intangible Assets:            
Identifiable Intangible Assets: 18,291,000          
Fair value of liabilities assumed:            
Accrued expenses and other current liabilities (362,000)          
Fair value of debt assumed (15,075,000)          
Fair value of contingent consideration (7,920,000)          
Total identifiable net assets (3,778,000)          
Fair value of consideration transferred 1          
Goodwill 3,778,001          
Measurement Period Adjustments            
Inventory     (1,831,000)      
Prepaid assets     570,000      
Intangible assets     1,838,000      
Accrued expenses     362,000      
Fair value of debt assumed     197,303      
Fair value of contingent consideration     (44,835)      
Total net liabilities assumed     367,468      
Consideration exchanged     (240,999)      
Goodwill     $ (608,467)      
TRx            
Business Acquisition [Line Items]            
Cash and cash equivalents   $ 11,068        
Accounts receivable, net   2,872,545        
Inventory   495,777        
Prepaid expenses and other current assets   134,281        
Other receivables   2,764,515        
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   19,596,000        
Total assets acquired   25,874,186        
Fair value of liabilities assumed:            
Accounts payable   192,706        
Accrued expenses and other current liabilities   (8,614,937)        
Deferred tax liability   918,613        
Total liabilities assumed   9,726,256        
Total identifiable net assets   16,147,930        
Fair value of consideration transferred   28,781,052        
Goodwill   12,633,122        
Measurement Period Adjustments            
Accounts receivable, net       $ 0    
Inventory       0    
Prepaid assets       0    
Other receivables       2,764,515    
Intangible assets       1,528,000    
Total assets acquired       4,292,515    
Accounts payable       0    
Accrued expenses       3,764,515    
Deferred tax liability       78,840    
Fair value of contingent consideration       1,210,000    
Total liabilities assumed       3,843,355    
Total net liabilities assumed       449,160    
Consideration exchanged       (1,210,000)    
Goodwill       (1,659,160)    
PAI Sales & Marketing Agreement | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   2,553,000        
Measurement Period Adjustments            
Intangible assets       219,000    
Metafolin | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   11,987,000        
Measurement Period Adjustments            
Intangible assets       1,522,000    
Millipred | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   5,056,000        
Measurement Period Adjustments            
Intangible assets       342,000    
Ulesfia | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   0        
Measurement Period Adjustments            
Intangible assets       $ (555,000)    
Previously Reported | Avadel            
Business Acquisition [Line Items]            
Inventory 2,549,000          
Prepaid expenses and other current assets 0          
Identifiable Intangible Assets:            
Identifiable Intangible Assets: 16,453,000          
Fair value of liabilities assumed:            
Accrued expenses and other current liabilities 0          
Fair value of debt assumed (15,272,303)          
Fair value of contingent consideration (7,875,165)          
Total identifiable net assets (4,145,468)          
Fair value of consideration transferred 241,000          
Goodwill $ 4,386,468          
Previously Reported | TRx            
Business Acquisition [Line Items]            
Cash and cash equivalents   11,068        
Accounts receivable, net   2,872,545        
Inventory   495,777        
Prepaid expenses and other current assets   134,281        
Other receivables   0        
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   18,068,000        
Total assets acquired   21,581,671        
Fair value of liabilities assumed:            
Accounts payable   192,706        
Accrued expenses and other current liabilities   (4,850,422)        
Deferred tax liability   839,773        
Total liabilities assumed   5,882,901        
Total identifiable net assets   15,698,770        
Fair value of consideration transferred   29,991,052        
Goodwill   14,292,282        
Previously Reported | PAI Sales & Marketing Agreement | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   2,334,000        
Previously Reported | Metafolin | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   10,465,000        
Previously Reported | Millipred | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   4,714,000        
Previously Reported | Ulesfia | Acquired product marketing rights | TRx            
Identifiable Intangible Assets:            
Identifiable Intangible Assets:   $ 555,000